Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001363246 | SCV001559350 | uncertain significance | Neuronal ceroid lipofuscinosis 7 | 2021-08-27 | criteria provided, single submitter | clinical testing | This sequence change replaces proline with alanine at codon 431 of the MFSD8 protein (p.Pro431Ala). The proline residue is highly conserved and there is a small physicochemical difference between proline and alanine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with MFSD8-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0". The alanine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001826024 | SCV002084760 | uncertain significance | Late-infantile neuronal ceroid lipofuscinosis | 2020-07-19 | no assertion criteria provided | clinical testing |